Author： Sankhala Kamalesh K Papadopoulos Kyriakos P
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.10, 2007-10, pp. : 1549-1560
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Imatinib mesilate for the treatment of gastrointestinal stromal tumour
By Cassier Philippe A Dufresne Armelle Arifi Samia Sayadi Hiba El Labidi Intidar Ray-Coquard Isabelle Tabone Séverine Méeus Pierre Ranchère Dominique Sunyach Marie-Pierre Decouvelaere Anne-Valérie Alberti Laurent Blay Jean-Yves
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. :
Access to resources
Recommend
Dasatinib deals to imatinib-resistant disease
Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. :
Nilotinib effective in imatinib-resistant/intolerant CML
Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. :